Overview
Coumarin derivative that acts as a long-acting oral anticoagulant.
Indication
Used for the prevention and treatment of thromboembolic disease including venous thrombosis, thromboembolism, and pulmonary embolism as well as for the prevention of ischemic stroke in patients with atrial fibrillation (AF).
Associated Conditions
- Myocardial Infarction
- Thrombosis
- Venous Embolism
Clinical Trials
Title | Posted | Study ID | Phase | Status | Sponsor |
|---|---|---|---|---|---|
2020/06/24 | N/A | Completed | |||
2018/06/20 | N/A | Completed | |||
2018/03/13 | Phase 4 | Completed | |||
2016/11/10 | N/A | Completed | |||
2016/10/14 | Phase 3 | Completed | Atrial Fibrillation Network | ||
2016/08/19 | Phase 2 | Terminated | Daniel Zimpfer, MD | ||
2015/10/29 | Phase 4 | UNKNOWN | University of Ulm | ||
2014/10/06 | Phase 2 | Terminated | Johannes Gutenberg University Mainz | ||
2014/03/18 | N/A | Completed | |||
2013/05/08 | Phase 1 | Completed |
FDA Drug Approvals
Approved Product | Manufacturer | NDC Code | Route | Strength | Effective Date |
|---|---|---|---|---|---|
| No FDA approvals found for this drug. | |||||
EMA Drug Approvals
Approved Product | Authorization Holder | Status | Issued Date |
|---|---|---|---|
| No EMA approvals found for this drug. | |||
HSA Drug Approvals
Approved Product | Manufacturer | Approval Number | Dosage Form | Strength | Approval Date |
|---|---|---|---|---|---|
| No HSA approvals found for this drug. | |||||
NMPA Drug Approvals
Approved Product | Company | Approval Number | Drug Type | Dosage Form | Approval Date |
|---|---|---|---|---|---|
| No NMPA approvals found for this drug. | |||||
PPB Drug Approvals
Approved Product | Registration No. | Company | Licence No. | Strength | Registration Date |
|---|---|---|---|---|---|
| No PPB approvals found for this drug. | |||||
TGA Drug Approvals
Approved Product | ARTG ID | Sponsor | Registration Type | Status | Registration Date |
|---|---|---|---|---|---|
| No TGA approvals found for this drug. | |||||
Help Us Improve
Your feedback helps us provide better drug information and insights.